首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-center retrospective case series
Authors:Anne Ari MD  Yael Levy MD  Nirit Segal MD  Ramit Maoz-Segal MD  Shira Benor MD  Arnon Broides MD  Amir Horev MD  Na'ama Epstein-Rigbi MD  Nancy Agmon-Levin MD  Nufar Marcus MD
Affiliation:1. Kipper Institute of Immunology and Allergy, Schneider Children's Medical Center of Israel, Petach Tikva, Israel;2. Kipper Institute of Immunology and Allergy, Schneider Children's Medical Center of Israel, Petach Tikva, Israel

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel;3. Clinical Immunology, Angioedema and Allergy Unit, Center for Autoimmune diseases, Sheba Medical Center, Tel Hashomer, Israel;4. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, University of Tel Aviv, Tel Aviv, Israel;5. Pediatric Immunology Clinic, Soroka University Medical Center & Faculty of Health Services, Ben-Gurion University of the Negev, Beer Sheva, Israel

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel;6. Pediatric Dermatology Services, Soroka University Medical Center & Faculty of Health Services, Ben-Gurion University of the Negev, Beer Sheva, Israel

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel;7. Institute of Allergy, Immunology, and Paediatric Pulmonology, Yitzhak Shamir Medical Centre, Beer Yaakov, Israel;8. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Clinical Immunology, Angioedema and Allergy Unit, Center for Autoimmune diseases, Sheba Medical Center, Tel Hashomer, Israel

Abstract:
Keywords:chronic urticaria  omalizumab  pediatric chronic urticaria  recalcitrant urticaria
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号